Gilead Sciences | 资产



Assets 更改 日
AbbVie USD 135.16B 8.26B 2024-12
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
ALKERMES USD 2.06B 99.72M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amgen USD 91.84B 956M 2024-12
Biogen USD 28.05B 263.9M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.75B 305.04M 2025-03
J&J USD 193.67B 13.57B 2025-03
Merck USD 117.11B 426M 2024-12
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sanofi 131.89B 906M 2025-03
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Gilead Sciences 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.